West Michigan Cancer Center
 

   News & Events      Breast Cancer Clinic      Glossary      FAQs      Suggestions      Contact   
        

   Patients

About WMCC
Services
Treatment Options
Insurance Information
Medical Team
Clinical Trials
Testimonials
Resources

   Referring Physicians

   Family & Friends
   Preventive Care

   Research

   Giving
   Employment

   Volunteering
My WMCC

 

Call For Recipes

 Clinical Trials: Ongoing Trials: 

Melanoma

Site/Type

Protocol Title
Adjuvant Surgical

ECOG E1697: Observation versus high dose Interferon (4 wks only) for stage IIA melanoma (T3-4 or N1)

Unresectable or Locally Advanced NONE
Metastatic

ECOG E1602: Multi-epitope Vaccination with Melanoma Peptides for cytotoxic T cells & helper T cells (Terminates 1/12/09)

ECOG E2602: Low dose Perinterferon Alfa-2B

ECOG S0438: BAY 43-9006 with either CCI0779 (Temsirolimus) or R115777 (Tipifarnib)

Skin Cancers

Site/Type

Protocol Title

Merkel Cell Cancer

None

Sarcomas

Site/Type

Advanced Disease / Unresectable

Soft Tissue

None

Extremities and Body Wall

None

Synovial Sarcoma

None
Leiomyosarcom of the Uterus GOG 231C: Sunitinib Malate (Sutent)
Mesothelioma None

Carcinoid Tumors

Stage

Protocol Title

Advanced

CTSU S518: Octreotide + Interferon alpha versus Octreotide + Bevacizumab

Neuroendocrine Tumors

Stage

Protocol Title
Low Grade
CTSU S518: Octreotide + Interferon alpha versus Octreotide + Bevacizumab
Advanced
 ECOG E4206: AMG 706 plus Octreotide

 

 


West Michigan Cancer Center • 200 North Park Street • Kalamazoo, MI 49007 • 269-382-2500